Fundraising Fox

Epitopea

Montreal, CA · Founded 2021 · 50 employees on LinkedIn · 10 known investors

Epitopea develops off-the-shelf cancer vaccines targeting aberrantly expressed tumor-specific antigens using its proprietary CryptoMap platform. The company serves patients with difficult-to-treat cancers across oncology.

AI & Machine LearningBiotechHealthtech

Founders & leadership

Epitopea was founded in 2021 by Claude Perreault and Pierre Thibault.

CPClaude Perreault
Claude Perreault
PTPierre Thibault
Pierre Thibault

Investors · 10

Advent Life SciencesLondon
Cambridge Innovation CapitalCambridge · $127K – $12.7M
CTI Life Sciences Fund L.P.Montréal
adMare BioInnovationsreportedVancouver
Fonds de solidarité FTQreportedMontreal

Also in the syndicate · 5

CTI Life SciencesHarrington Discovery InstituteInvestissement QuébecIRICoRNovateur Ventures

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

Competitors · 3

by search overlap
Epi Biologics8 shared keywordsEpibiologics develops protein degradation medicines using protein sciences and antibody engineering capabilities.
Epics Therapeutics7 shared keywordsEPICS Therapeutics develops RNA epigenetics-based cancer treatments, focusing on METTL3 inhibitors for cancers including non-small cell lung cancer, pancreatic cancer, ovarian cancer, and colorectal cancer where existing therapies are insufficient.
Predictive Oncology5 shared keywordsPredictive Oncology combines machine learning with data from a large privately held biobank of over 150,000 tumor samples and 3D in vitro tumor models to predict drug response for pre-clinical drug discovery. It also offers tumor drug-response testing and genomic profiling services to personalize cancer therapies, serving biopharma partners and clinical oncology.

Companies competing with Epitopea for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Epitopea Closes USD $31 million Pre-Series A Financingglobenewswire.com · Oct 2024IRICoR | Epitopea raises seed financing – $ 14Miricor.ca · May 2022Advancing cancer treatments, medtech startup Epitopea raises £10.3 million - Tech.eutech.eu · Apr 2022Epitopea Raises $13.6M in Seed Fundingfinsmes.com · Apr 2022News & Events - Epitopeaepitopea.com · Apr 2022

Frequently asked questions

What does Epitopea do?
Epitopea develops off-the-shelf cancer vaccines targeting aberrantly expressed tumor-specific antigens using its proprietary CryptoMap platform. The company serves patients with difficult-to-treat cancers across oncology.
Who founded Epitopea?
Epitopea was founded by Claude Perreault, Pierre Thibault in 2021.
Who are Epitopea's investors?
Epitopea's investors include Advent Life Sciences, Cambridge Innovation Capital, CTI Life Sciences Fund L.P., adMare BioInnovations, Fonds de solidarité FTQ.
Where is Epitopea headquartered?
Epitopea is headquartered in Montreal, CA.